Zobrazeno 1 - 10
of 167
pro vyhledávání: ''
Autor:
Amy Lin, Paola Cinque, Carmela Pinnetti, Valeria De Zan, Alan Winston, Andrea Calcagno, Gustaf Ulfhammer, Bruce J Brew, Arvid Edén, Staffan Nilsson, Cristiana Oprea, Mattia Trunfio, Lars Hagberg, Andrea Antinori, Richard W. Price, Magnus Gisslén, Serena Spudich
Publikováno v:
Clinical Infectious Diseases. 75:493-502
Background The aim of this large multicenter study was to determine variations in cerebrospinal fluid (CSF) HIV-RNA in different phases of untreated human immunodeficiency virus type 1 (HIV-1) infection and its associations with plasma HIV-RNA and ot
Autor:
Deborah Langat, Jyoti S. Mathad, Jennifer Norman, Amita Gupta, Impaact Study Team, Lubbe Wiesner, Stephanie Popson, Nahida Chakhtoura, Nan Zhang, Kelly E. Dooley, Tsungai Chipato, Amphan Chalermchockcharoentkit, Portia Kamthunzi, Ellen Townley, Priya Jayachandran, Rada M. Savic, Sarah Bradford, Grace Montepiedra, Paula Britto, Vanessa Rouzier, Sandesh Patil
Publikováno v:
Clinical Infectious Diseases. 74:1604-1613
Background Pregnancy increases the risk of tuberculosis and its complications. A 3-month regimen of weekly isoniazid and rifapentine (3HP) is safe and effective for tuberculosis prevention in adults and children, including those with HIV, but 3HP has
Publikováno v:
Clinical Infectious Diseases. 73:1965-1972
Background Severe malaria can be deadly and requires treatment with intravenous artesunate (IVAS). The Centers for Disease Control and Prevention provided IVAS starting 1 April 2019 for all patients with severe malaria in the United States. This stud
Autor:
Chinmay Laxmeshwar, Fatima Mamnoon, Petros Isaakidis, Augusto C Meneguim, Farah Naz Hossain, Taanya Mathur, Alpa Dalal, Stobdan Kalon, N Lachenal, Homa Mansoor, Sylvine Coutisson, Mrinalini Das, Pramila Singh, Roma Paryani, Gabriella Ferlazzo, Shilpa Ravi
Publikováno v:
Clinical Infectious Diseases. 73:e3496-e3504
Background The Médecins Sans Frontières Clinic in Mumbai, India, has been providing concomitant bedaquiline (BDQ) and delamanid (DLM) in treatment regimen for patients with drug-resistant tuberculosis (DR-TB) and limited therapeutic options, referr
Autor:
Trevor A Crowell, Julie A Ake, Emmanuel Bahemana, John Owuoth, Jennifer A. Malia, Jonah Maswai, Michael Iroezindu, Christina S Polyak, Joanna Freeman, Sheila A. Peel, Ajay Parikh, Peter Coakley, Sodsai Tovanabutra, Alex Kasembeli, Francis Kiweewa, Linda L. Jagodzinski, Leigh Ann Eller, Allahna Esber, Samoel Khamadi, Nicole Dear, Brook A Danboise
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background Emerging HIV drug resistance (HIVDR) could jeopardize the success of standardized HIV management protocols in resource-limited settings. We characterized HIVDR among antiretroviral therapy (ART)-naive and experienced participants in the Af
Autor:
Saorin Kim, Chhayleang Kauy, Maria Dorina Bustos, Nimol Kloeung, Rotha Eam, Nimol Khim, Denis Mey Bouth, Sopheakvatey Ke, Brigitte Izac, Benoit Witkowski, Rithea Leang, Melissa Mairet-Khedim, Pascal Ringwald, Frédéric Ariey, Camille Marmai, Sophy Chy
Publikováno v:
Clinical Infectious Diseases
Clinical Infectious Diseases, Oxford University Press (OUP), 2021, 73 (3), pp.406-413. ⟨10.1093/cid/ciaa628⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 2021, 73 (3), pp.406-413. ⟨10.1093/cid/ciaa628⟩
Clinical Infectious Diseases, Oxford University Press (OUP), 2021, 73 (3), pp.406-413. ⟨10.1093/cid/ciaa628⟩
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases, 2021, 73 (3), pp.406-413. ⟨10.1093/cid/ciaa628⟩
Background Artesunate-amodiaquine is a potential therapy for uncomplicated malaria in Cambodia. Methods Between September 2016 and January 2017, artesunate-amodiaquine efficacy and safety were evaluated in a prospective, open-label, single-arm observ
Autor:
Judith A. Hahn, Robin Fatch, Dalsone Kwarisiima, Gabriel Chamie, Brian Beesiga, Sarah B Puryear, Kara Marson, Nneka Emenyonu, Sara Lodi, Allen Kekibiina, Winnie Muyindike
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 72, iss 5
Clin Infect Dis
Clin Infect Dis
We assessed associations between hazardous alcohol use and latent tuberculosis infection (LTBI) among adults living with human immunodeficiency virus (HIV) in Uganda. We compared tuberculin skin test positivity across medium, high, and very-high alco
Autor:
Caitlin R. Rausch, Kiran Naqvi, Prithviraj Bose, Wei Qiao, Zeev Estrov, Musa Yilmaz, Kayleigh Marx, Xuelin Huang, Carol Bivins, David McCue, Tapan M. Kadia, Lucia Masarova, Naval Daver, Dimitrios P. Kontoyiannis, Naveen Pemmaraju, Hagop M. Kantarjian, Nathan P. Wiederhold, Koichi Takahashi, Farhad Ravandi, Sherry Pierce, Sebastian Wurster, Marina Konopleva, Gautam Borthakur
Publikováno v:
Clin Infect Dis
Background Mold-active primary antifungal prophylaxis (PAP) is routinely recommended in neutropenic patients with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) undergoing remission-induction chemotherapy (RI
Autor:
Ekaterine Adamia, Stefan Zeuzem, Francisco Averhoff, Sanjeev Arora, Lia Gvinjilia, Akaki Abutidze, Amiran Gamkrelidze, Nezam H. Afdhal, Muazzam Nasrullah, Beth Skaggs, Karla Thornton, David Metreveli, Nikoloz Chkhartishvili, Maia Butsashvili, Vakhtang Kerashvili, Tengiz Tsertsvadze, Shaun Shadaker, Maia Lagvilava, Lali Sharvadze, Tinatin Kuchuloria, David Sergeenko
Publikováno v:
Clin Infect Dis
Background In April 2015, in collaboration with the US Centers for Disease Control and Prevention and Gilead Sciences, the country of Georgia embarked on the world’s first hepatitis C elimination program. We aimed to assess progress toward eliminat
Autor:
Joy Beeler, John H. Beigel, Justin Hoopes, H. Clifford Lane, Michael G. Ison, Christopher A Myers, Anchalee Avihingsanon, Kiat Ruxrungtham, Richard T. Davey, Weerawat Manosuthi, Michael Hughes, H Preston Holley, Marcelo H. Losso, Richard L Beasley, Nicholas Langlois, Melanie Hoppers, Yajing Bao
Publikováno v:
Clin Infect Dis
Background Duration of viral shedding is a determinant of infectivity and transmissibility, but few data exist about oseltamivir's ability to alter viral shedding. Methods From January 2012 through October 2017, a randomized, double-blinded multicent